Zoetis Inc

NYSE ZTS

Data sourced from

and

Download Data

Zoetis Inc Average Collection Period 3 year CAGR for the year ending December 31, 2023: -0.51%

Zoetis Inc Average Collection Period 3 year CAGR is -0.51% for the year ending December 31, 2023, a 88.48% change year over year. The average collection period measures the average number of days it takes for a company to collect payments from its customers. It is calculated by dividing 365 by the ratio of revenue to the average of receivables and other current assets. A lower average collection period indicates a more efficient collection process and better cash flow management, while a higher period may suggest delayed payments and potential liquidity challenges. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.

Zoetis Inc Average Collection Period for the year ending December 31, 2022 was 35.69, a -0.09% change year over year.
Zoetis Inc Average Collection Period for the year ending December 31, 2021 was 35.72, a -5.26% change year over year.
Zoetis Inc Average Collection Period for the year ending December 31, 2020 was 37.70, a -7.89% change year over year.
Zoetis Inc Average Collection Period for the year ending December 31, 2019 was 40.93, a -0.04% change year over year.

NYSE: ZTS

Zoetis Inc

CEO	Ms. Kristin C. Peck
IPO Date	Feb. 1, 2013
Location	United States
Headquarters	10 Sylvan Way, Parsippany, NJ, United States, 07054
Employees	14,100
Sector	Healthcare
Industry	Drug manufacturers - specialty & generic

Description

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Key trends